Martin J Everett (Martin Everett)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Topics

Biofilm Formation

Multidrug Resistant

Urinary Tract Infection

Acinetobacter Baumannii

Top Venues

ACS infectious diseases

Antimicrobial agents and chemotherapy

Accounts of chemical research

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Martin J Everett, David T Davies, Simon Leiris, Nicolas Sprynski, Agustina Llanos, Jérôme M Castandet, Clarisse Lozano, Christopher N LaRock, Doris L LaRock, Giuseppina Corsica, Jean-Denis Docquier, Thomas David Pallin, Andrew Cridland, Toby Blench, Magdalena Zalacain, Marc Lemonnier
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS infectious diseases 9 (2) (2023)
Martin J Everett, David T Davies, Simon Leiris, Nicolas Sprynski, Agustina Llanos, Jérôme M Castandet, Clarisse Lozano, Christopher N LaRock, Doris L LaRock, Giuseppina Corsica, Jean-Denis Docquier, Thomas David Pallin, Andrew Cridland, Toby Blench, Magdalena Zalacain, Marc Lemonnier
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS infectious diseases 9 (2) (2023)
Martin J Everett, David T Davies, Simon Leiris, Nicolas Sprynski, Agustina Llanos, Jérôme M Castandet, Clarisse Lozano, Christopher N LaRock, Doris L LaRock, Giuseppina Corsica, Jean-Denis Docquier, Thomas David Pallin, Andrew Cridland, Toby Blench, Magdalena Zalacain, Marc Lemonnier
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS infectious diseases 9 (2) (2023)
Martin J Everett, David T Davies, Simon Leiris, Nicolas Sprynski, Agustina Llanos, Jérôme M Castandet, Clarisse Lozano, Christopher N LaRock, Doris L LaRock, Giuseppina Corsica, Jean-Denis Docquier, Thomas David Pallin, Andrew Cridland, Toby Blench, Magdalena Zalacain, Marc Lemonnier
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS infectious diseases 9 (2) (2023)
Martin J Everett, David T Davies, Simon Leiris, Nicolas Sprynski, Agustina Llanos, Jérôme M Castandet, Clarisse Lozano, Christopher N LaRock, Doris L LaRock, Giuseppina Corsica, Jean-Denis Docquier, Thomas David Pallin, Andrew Cridland, Toby Blench, Magdalena Zalacain, Marc Lemonnier
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS infectious diseases (2023)
Martin J Everett, David T Davies, Simon Leiris, Nicolas Sprynski, Agustina Llanos, Jérôme M Castandet, Clarisse Lozano, Christopher N LaRock, Doris L LaRock, Giuseppina Corsica, Jean-Denis Docquier, Thomas David Pallin, Andrew Cridland, Toby Blench, Magdalena Zalacain, Marc Lemonnier
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS infectious diseases 9 (2) (2023)
Martin J Everett, David T Davies, Simon Leiris, Nicolas Sprynski, Agustina Llanos, Jérôme M Castandet, Clarisse Lozano, Christopher N LaRock, Doris L LaRock, Giuseppina Corsica, Jean-Denis Docquier, Thomas David Pallin, Andrew Cridland, Toby Blench, Magdalena Zalacain, Marc Lemonnier
Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS infectious diseases 9 (2) (2023)
Shampa Das, Martin J Everett, Magdalena Zalacain, William W Hope
Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models". Antimicrobial agents and chemotherapy 65 (2) (2021)
Magdalena Zalacain, Clarisse Lozano, Agustina Llanos, Nicolas Sprynski, Thomas Valmont, Cyntia De Piano, David Davies, Simon Leiris, Carole Sable, Adeline Ledoux, Ian Morrissey, Marc Lemonnier, Martin J Everett
Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Enterobacterales. Antimicrobial agents and chemotherapy 65 (6) (2021)
David T Davies, Martin J Everett
Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria. Accounts of chemical research 54 (9) (2021)
David T Davies, Simon Leiris, Nicolas Sprynski, Jérôme M Castandet, Clarisse Lozano, Justine Bousquet, Magdalena Zalacain, Srinivas Vasa, Praveen K Dasari, Ramesh Pattipati, Naresh Vempala, Swetha Gujjewar, SyamKumar Godi, Raju Jallala, Rajashekar Reddy Sathyap, Narasimha A Darshanoju, Vengala R Ravu, Ramakrishna R Juventhala, Narender Pottabathini, Somesh Sharma, Srinivasu Pothukanuri, Kirsty Holden, Peter Warn, Francesca Marcoccia, Manuela Benvenuti, Cecilia Pozzi, Stefano Mangani, Jean Denis Docquier, Marc Lemonnier, Martin J Everett
ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae. ACS infectious diseases 6 (9) (2020)
David T Davies, Simon Leiris, Magdalena Zalacain, Nicolas Sprynski, Jérôme Castandet, Justine Bousquet, Clarisse Lozano, Agustina Llanos, Laethitia Alibaud, Srinivas Vasa, Ramesh Pattipati, Ravindar Valige, Bhaskar Kummari, Srinivasu Pothukanuri, Cyntia De Piano, Ian Morrissey, Kirsty Holden, Peter Warn, Francesca Marcoccia, Manuela Benvenuti, Cecilia Pozzi, Giusy Tassone, Stefano Mangani, Jean Denis Docquier, Thomas David Pallin, Richard Elliot, Marc Lemonnier, Martin J Everett
Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii. Journal of medicinal chemistry 63 (24) (2020)
Shampa Das, Adam Johnson, Laura McEntee, Nicola Farrington, Adam Kirby, Jennifer Unsworth, Ana Jimenez-Valverde, Ruwanthi Kolamunnage-Dona, Justine Bousquet, Laethitia Alibaud, Carole Sable, Magdalena Zalacain, Martin J Everett, William W Hope
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae. Antimicrobial agents and chemotherapy 64 (11) (2020)
Martin J Everett, Nicolas Sprynski, Alicia Coelho, Jérôme Castandet, Maëlle Bayet, Juliette Bougnon, Clarisse Lozano, David T Davies, Simon Leiris, Magdalena Zalacain, Ian Morrissey, Sophie Magnet, Kirsty Holden, Peter Warn, Filomena De Luca, Jean-Denis Docquier, Marc Lemonnier
Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae. Antimicrobial agents and chemotherapy 62 (5) (2018)
Simon Leiris, Alicia Coelho, Jérôme M Castandet, Maëlle Bayet, Clarisse Lozano, Juliette Bougnon, Justine Bousquet, Martin J Everett, Marc Lemonnier, Nicolas Sprynski, Magdalena Zalacain, Thomas David Pallin, Michael C Cramp, Neil Jennings, Gilles Raphy, Mark W Jones, Ramesh Pattipati, Battu Shankar, Relangi Sivasubrahmanyam, Ashok K Soodhagani, Ramakrishna R Juventhala, Narender Pottabathini, Srinivasu Pothukanuri, Manuela Benvenuti, Cecilia Pozzi, Stefano Mangani, Filomena De Luca, Giulia Cerboni, Jean Denis Docquier, David T Davies
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model. ACS infectious diseases 5 (1) (2018)